On Feb. 21, 2022, China NMPA issued the Management of Cosmetic Adverse Reaction Monitoring, which is China's first regulation specifically for the management of cosmetic adverse reaction monitoring.

It consists of 7 chapters and 47 articles, as shown shown as follows:

• Chapter I General Provisions

• Chapter II Responsibilities and Obligations

• Chapter III Adverse Reaction Reporting

• Chapter IV Analysis and Evaluation of Adverse Reactions

• Chapter V Adverse Reaction Investigation

• Chapter VI Supervision and Management

• Chapter VII Supplementary Provisions